Biofilm formation, antibiotic susceptibility and RAPD genotypes in Pseudomonas aeruginosa clinical strains isolated from single centre intensive care unit patients

. 2017 Nov ; 62 (6) : 531-538. [epub] 20170401

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid28365878

Grantová podpora
16-31593A Grant of Ministry of Health, CZ
201404 Internal grant of the Centre for Cardiovascular Surgery and Transplantation Brno, CZ

Odkazy

PubMed 28365878
DOI 10.1007/s12223-017-0526-7
PII: 10.1007/s12223-017-0526-7
Knihovny.cz E-zdroje

The aim of this study was to analyse genotypes, antimicrobial susceptibility patterns and serotypes in Pseudomonas aeruginosa clinical strains, including the clonal dissemination of particular strains throughout various intensive care units in one medical centre. Using random amplified polymorphic DNA (RAPD-PCR) and P. aeruginosa antisera, 22 different genotypes and 8 serotypes were defined among 103 isolates from 48 patients. No direct association between P. aeruginosa strain genotypes and serotypes was observed. RAPD typing in strains with the same serotype revealed different genotypes and, on the contrary, most strains with a different serotype displayed the same amplification pattern. The resulting banding patterns showed a high degree of genetic heterogeneity among all isolates from the patients examined, suggesting a non-clonal relationship between isolates from these patients. A higher degree of antibiotic resistance and stronger biofilm production in common genotypes compared to rare ones and genetic homogeneity of the most resistant strains indicated the role of antibiotic pressure in acquiring resistant and more virulent strains in our hospital. In conclusion, genetic characterisation of P. aeruginosa strains using RAPD method was shown to be more accurate in epidemiological analyses than phenotyping.

Zobrazit více v PubMed

BMC Microbiol. 2005 May 20;5:29 PubMed

J Clin Microbiol. 2013 Feb;51(2):665-8 PubMed

J Antimicrob Chemother. 2008 Mar;61(3):714-20 PubMed

Braz J Microbiol. 2012 Jan;43(1):274-82 PubMed

J Microbiol Methods. 2011 Feb;84(2):167-73 PubMed

J R Soc Med. 2002;95 Suppl 41:22-6 PubMed

Res Microbiol. 2010 Apr;161(3):234-42 PubMed

Pharmacotherapy. 2005 Oct;25(10):1353-64 PubMed

Antimicrob Agents Chemother. 2005 Sep;49(9):3663-7 PubMed

Jpn J Infect Dis. 2007 May;60(2-3):82-6 PubMed

J Clin Microbiol. 1996 Dec;34(12):3190-5 PubMed

J Clin Microbiol. 1996 May;34(5):1129-35 PubMed

Am J Med. 2006 Jun;119(6):526.e19-25 PubMed

Salud Publica Mex. 2004 Mar-Apr;46(2):149-57 PubMed

BMC Microbiol. 2010 Feb 08;10:38 PubMed

J Hosp Infect. 2016 Jan;92 (1):54-60 PubMed

Antimicrob Agents Chemother. 1999 Apr;43(4):981-2 PubMed

FEMS Immunol Med Microbiol. 2007 Dec;51(3):505-16 PubMed

Clin Infect Dis. 2004 Mar 1;38(5):670-7 PubMed

J Clin Microbiol. 2003 Mar;41(3):1192-202 PubMed

APMIS. 2007 Aug;115(8):891-9 PubMed

Front Microbiol. 2015 Jan 21;5:802 PubMed

Int J Hyg Environ Health. 2006 Jul;209(4):325-31 PubMed

Int J Med Microbiol. 2007 Sep;297(5):277-95 PubMed

Iran J Microbiol. 2010 Jun;2(2):85-8 PubMed

J Bacteriol. 1999 Jul;181(14):4275-84 PubMed

Antimicrob Agents Chemother. 2010 Sep;54(9):3717-22 PubMed

Zentralbl Bakteriol. 2000 Jan;289(8):857-67 PubMed

Lett Appl Microbiol. 2004;39(3):274-7 PubMed

J Antimicrob Chemother. 1991 Dec;28(6):869-75 PubMed

Burns. 2013 Nov;39(7):1409-13 PubMed

Emerg Infect Dis. 1998 Oct-Dec;4(4):551-60 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace